[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hyperthermic-intraperitoneal-chemoperfusion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hyperthermic-intraperitoneal-chemoperfusion":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":5},"100617050","hyperthermic-intraperitoneal-chemoperfusion-hipec-in-gastric-cancer-100617050",false,"NCT07313579","Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer","Observational Prospective Cohort Study on Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer","G-PEC","Inclusion Criteria:\n\n1. Age 18-80\n2. Hystologicaly proven gastric adenocarcinoma\n3. ECOG status 0-1\n4. Written consent to participate in the study\n5. Medically and technically operable gastric tumor\n6. Only T4a or T4b tumours with any peritoneal cytology status\n7. Cytologically positive peritoneal washings (cyt+) with any T and N criteria\n8. Adequate haemopoetic, renal and hepatic function (Hb \\> 120, PLT \\> 150\\*10\\^9\u002Fl, ALT \\\u003C 60, AST \\\u003C40, total bilirubin \\\u003C 21 µmol\u002Fl, Creatinine clearance (male - 90-140, female - 80-130 ml\u002Fmin)\n\nExclusion Criteria:\n\n1. Pregnancy\u002Fbreastfeeding\n2. ECOG status 2-4\n3. Concomitant malignancy\n4. Mitomycin and\u002For Cisplatin hypersensitivity\n5. Uncontrollable chronic diseases\n6. Patients with coexisting malignancy other than basal cell carcinoma of the skin within the last five years.\n7. Presence of metastases other than regional or peritoneal (such as liver, lungs, bone, brain, distant lymph nodes)\n8. History of allergic reactions associated with cisplatin and Mitomycin C\n9. Patients with psychiatric illness\u002Fsocial situations with impaired compliance\n10. •Refusal to participate","ALL","18 Years","80 Years",{"count":21,"type":22},200,"ESTIMATED","OBSERVATIONAL","The study investigates the outcomes of hyperthermic intraperitoneal chemoperfusion (HIPEC) in combination with curative-intent gastrectomy in resectable locally-advanced and limited-metastatic (low peritoneal cancer index) gastric cancer.",[26,27,28,29],"Gastric Cancer (GC)","HIPEC","Peritoneal Metastases From Gastric Cancer","Hyperthermic Intraperitoneal Chemoperfusion",[31,27,29,32,33,34,35,36,37,38,39,40,41,42],"Gastric cancer","FLOT","Lymphadenectomy","Gastrointestinal Neoplasms","Digestive System Neoplasms","Gastrointestinal Diseases","Stomach Diseases","Stomach Neoplasms","Chemotherapy, Adjuvant","Combined Modality Therapy","Drug Therapy","Surgical Procedures","RECRUITING","2026-01-10",{"date":46,"type":47},"2026-01-13","ACTUAL",{"date":49,"type":47},"2025-12-01",{"date":51,"type":22},"2035-12-01",{"name":53,"class":54},"Ukrainian Society of Clinical Oncology","OTHER"]